O

Orchestra BioMed Holdings
D

OBIO

6.80000
USD
-0.58
(-7.86%)
مغلق
حجم التداول
1,805
الربح لكل سهم
0
العائد الربحي
0
P/E
-4
حجم السوق
236,025,323
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: Orchestra BioMed Holdings

القطاع: Healthcare
الصناعة: Biotechnology
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborationswith medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.